We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Comply with good pharmacovigilance practice and prepare for an inspection.
How to carry out a flood risk assessment so that you can complete your planning application.
How to use an ethnographic study to evaluate your digital health product.
Guidance for industry on flexible approaches we are taking on good distribution practices.
Information on good laboratory, manufacturing and distribution practice, good pharmacovigilance practice (GPvP), out-of-specification investigations, inspection metrics and fees.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
The UK Good Laboratory Practice Monitoring Authority (UK GLPMA) recognises that there are potential challenges COVID-19 will present to members of the GLP monitoring programme.
Helping public health practitioners conducting evaluations – choosing evaluation methods.
Compare different evaluation approaches and choose an appropriate method.
How to use a before-and-after study to evaluate your digital health product.
Practice notices announce changes to our practice, such as how we interpret a provision of the law, or how we handle applications.
How to use a contextual inquiry when developing your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.